These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20639814)

  • 1. PET imaging of the immune system: immune monitoring at the whole body level.
    Singh AS; Radu CG; Ribas A
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):281-90. PubMed ID: 20639814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Imaging for Monitoring Cellular and Immunotherapy of Cancer.
    Larimer BM
    Cancer J; 2024 May-Jun 01; 30(3):153-158. PubMed ID: 38753749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
    Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
    Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the potential of noninvasive in vivo preclinical imaging of the immune system: challenges and prospects.
    Diken M; Pektor S; Miederer M
    Nanomedicine (Lond); 2016 Oct; 11(20):2711-2722. PubMed ID: 27628499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Imaging of Immunotherapy Targets in Cancer.
    Ehlerding EB; England CG; McNeel DG; Cai W
    J Nucl Med; 2016 Oct; 57(10):1487-1492. PubMed ID: 27469363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging the immune response to monitor tumor immunotherapy.
    Wang Q; Ornstein M; Kaufman HL
    Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive imaging of adaptive immunity using positron emission tomography.
    Nair-Gill ED; Shu CJ; Radu CG; Witte ON
    Immunol Rev; 2008 Feb; 221():214-28. PubMed ID: 18275485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive T-cell therapy: a need for standard immune monitoring.
    Klaver Y; Kunert A; Sleijfer S; Debets R; Lamers CH
    Immunotherapy; 2015; 7(5):513-33. PubMed ID: 26065477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking cellular and immune therapies in cancer.
    Kurtz DM; Gambhir SS
    Adv Cancer Res; 2014; 124():257-96. PubMed ID: 25287692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo imaging of tumor-infiltrating immune cells: implications for cancer immunotherapy.
    Zeelen C; Paus C; Draper D; Heskamp S; Signore A; Galli F; Griessinger CM; Aarntzen EH
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):56-77. PubMed ID: 29191000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Imaging for Cancer Immunotherapy: Seeing Is Believing.
    Saeed M; Xu Z; De Geest BG; Xu H; Yu H
    Bioconjug Chem; 2020 Feb; 31(2):404-415. PubMed ID: 31951380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming tumor-mediated immunosuppression.
    Schlößer HA; Theurich S; Shimabukuro-Vornhagen A; Holtick U; Stippel DL; von Bergwelt-Baildon M
    Immunotherapy; 2014; 6(9):973-88. PubMed ID: 25341119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive PET Imaging of T cells.
    Wei W; Jiang D; Ehlerding EB; Luo Q; Cai W
    Trends Cancer; 2018 May; 4(5):359-373. PubMed ID: 29709260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome Prediction and Evaluation by Imaging the Key Elements of Therapeutic Responses to Cancer Immunotherapies Using PET.
    Bu L; Sun Y; Han G; Tu N; Xiao J; Wang Q
    Curr Pharm Des; 2020; 26(6):675-687. PubMed ID: 31465273
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    McCarthy CE; White JM; Viola NT; Gibson HM
    Front Immunol; 2020; 11():1067. PubMed ID: 32582173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PET in imaging of the tumour microenvironment and response to immunotherapy.
    Lilburn DML; Groves AM
    Clin Radiol; 2021 Oct; 76(10):784.e1-784.e15. PubMed ID: 34503671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade.
    Weber J
    Semin Oncol; 2010 Oct; 37(5):430-9. PubMed ID: 21074057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of novel immunotherapy targeting cancer immune evasion].
    Tamada K
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in PET Detection of the Antitumor T Cell Response.
    McCracken MN; Tavaré R; Witte ON; Wu AM
    Adv Immunol; 2016; 131():187-231. PubMed ID: 27235684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granzyme B PET imaging of immune-mediated tumor killing as a tool for understanding immunotherapy response.
    LaSalle T; Austin EE; Rigney G; Wehrenberg-Klee E; Nesti S; Larimer B; Mahmood U
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.